http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104395479-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate | 2013-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104395479-B |
| titleOfInvention | The biomarker of diabetes |
| abstract | The present invention provides a kind of method, by detecting the sequence variations in one or more genes (such as Carboxypeptidase E (CPE) and insulin-degrading enzyme (IDE)), come diagnosed type 2 diabetic, all sites cancer or cardiovascular disease, and can be used for assessing subject and suffer from the risk for stating disease.Additionally provide the kit, array and device for implementing the method.In addition, the present invention provides a kind of method, for treating the diabetes B, all sites cancer or the cardiovascular patient that have been demonstrated correlative heritability through detecting. |
| priorityDate | 2012-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 469.